The compound 1,2,4-Trimethyl-3-nitrobicyclo [3.3.1]nonan-9-one shows binding features with the cancer target protein RAD51 similar to the FDA approveddrug of 5-Flurouracil for further consideration in the context of pancreatic cancer drug discovery. This evidence concerns the gene RAD51 and pancreatic neoplasm.